LOGIN
Nabilone well-tolerated, but weaker analgesic than dihydrocodeine for neuropathic pain
October 2018
Nabilone well-tolerated, but weaker analgesic than dihydrocodeine for neuropathic pain
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: Randomised, crossover, double blind study
BMJ. 2008 26-Jan;336(7637):199-201. http://dx.doi.org/10.1136/bmj.39429.619653.80Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
96 patients with chronic neuropathic pain received increasing doses of nabilone and dihydrocodeine for 6-week periods in random order with a 2-week washout period. The purpose of the study was to compare the effect of nabilone on pain, quality of life (SF-36), and adverse events to that of dihydrocodeine. The results indicated that dihydrocodeine provided better analgesic effect, SF-36 scores for ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.